Citations

Showing 10 of 108119 citations.

Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors
Leaf, Rebecca Karp , Ferreri, Christopher, Rangachari, Deepa, Mier, James W., Witteles, Wesley, Ansstas, George , Zubiri, Leyre , Oo, Thein Hlaing , Iberri, David , Yarchoan, Mark , Salama, April K.S. , Johnson, Douglas B. , Leavitt, Andrew D. , Rahma, Osama E. , Reynolds, Kerry L. , Leaf, David E. , Anagnostou, Theodora , Oo, Thein H , Iberri, David , Leaf, David E , Zubiri, Leyre , Yarchoan, Mark , Rangachari, Deepa , Piotrowska, Zofia

Mayo Clinic

American Journal of Hematology | February 21, 2019 | Volume: 94 | Issue: 5 | Pages: 563-574

10.1002/ajh.25448 | PMID 30790338 Get It

AbstractImmune checkpoint inhibitors (ICPis) are a novel class of immunotherapeutic agents that have revolutionized the treatment of cancer; however, these drugs can also cause a unique spectrum of autoimmune toxicity. Autoimmune hemolytic anemia (AIHA) is a rare, but often severe, complication of ICPis. We identified 14 patients from nine institutions across the United States who developed ICPi‐AIHA. The median interval from ICPi initiation to development of AIHA was 55 days (interquartile range [IQR], 22‐110 days). Results from the direct antiglobulin test (DAT) were available for 13 of 14 patients: 8 patients (62%) had a positive DAT and 5 (38%) had a negative DAT. The median pretreatment and nadir hemoglobin concentrations were 11.8 g/dL (IQR, 10.2‐12.9 g/dL) and 6.3 g/dL (IQR, 6.1‐8.0 g/dL), respectively. Four patients (29%) had a preexisting lymphoproliferative disorder, and two (14%) had a positive DAT prior to initiation of ICPi therapy. All patients were treated with glucocorticoids, with three requiring additional immunosuppressive therapy. Complete and partial recoveries of hemoglobin were achieved in 12 (86%) and 2 (14%) patients, respectively. Seven patients (50%) were rechallenged with ICPis, and one (14%) developed recurrent AIHA. Clinical and laboratory features of ICPi‐AIHA were similar in DAT positive and negative patients. ICPi‐AIHA shares many clinical features with primary AIHA; however, a unique aspect of ICPi‐AIHA is a high incidence of DAT negativity. Glucocorticoids are an effective first‐line treatment in the majority of patients with ICPi‐AIHA, and most patients who are rechallenged with an ICPi do not appear to develop recurrence of AIHA.
Testing the radiochemical purity of technetium Tc 99m-labeled radiopharmaceuticals
Hung, Joseph C., Budde, Pamela A., Wilson, Mark E., Wilson, Mark E.

Mayo Clinic

American Journal of Health-System Pharmacy | February 21, 2019 | Volume: 52 | Issue: 3 | Pages: 310-313

10.1093/ajhp/52.3.310 | PMID 7749960 Get It

A near‐haploid clone harboring a BCR/ABL1 gene fusion in an adult patient with newly diagnosed B‐lymphoblastic leukemia
Peterson, Jess F. , Finn, Laura , Hoppman, Nicole L., Greipp, Patricia T. , Peterson, Jess F , Greipp, Patricia T , Ketterling, Rhett P. , Huang, Li , Shi, Min , Baughn, Linda B.

Mayo Clinic

Genes, Chromosomes and Cancer | February 21, 2019 | Volume: 58 | Issue: 9 | Pages: 665-668

10.1002/gcc.22744 | PMID 30790375 Get It

AbstractThe detection of recurrent genetic abnormalities in B‐lymphoblastic leukemia (B‐ALL) is critical for risk stratification and therapy‐related decisions. Near‐haploidy (24‐30 chromosomes), a subgroup of hypodiploidy (<46 chromosomes), and BCR/ABL1 gene fusions are both recurrent genetic abnormalities in B‐ALL and are considered adverse prognostic findings, although outcomes in BCR/ABL1‐positive patients have improved with tyrosine kinase inhibitor therapy. While near‐haploid clones are primarily observed in children and rarely harbor structural abnormalities, BCR/ABL1‐positive B‐ALL is primarily observed in adults. Importantly, recurrent genetic abnormalities are considered mutually exclusive and rarely exist within the same neoplastic clone. We report only the second case to our knowledge of a near‐haploid clone that harbors a BCR/ABL1 fusion in an adult with newly diagnosed B‐ALL. Conventional chromosome studies revealed a near‐haploid clone (27 chromosomes) along with a der(22)t(9;22)(q34.1;q11.2) in 17 of 20 metaphases analyzed. Our B‐ALL fluorescence in situ hybridization (FISH) panel confirmed the BCR/ABL1 fusion and monosomies consistent with chromosome studies in approximately 95% of interphase nuclei. Moreover, no evidence of a “doubled” near‐haploid clone was observed by chromosome or FISH studies. This highly unusual case illustrates that while rare, recurrent genetic abnormalities in B‐ALL can exist within the same neoplastic clone.
In Response
Hanson, Andrew C. , Kor, Daryl J. , Warner, Matthew A.

Mayo Clinic

Anesthesia & Analgesia | February 21, 2019 | Volume: 128 | Issue: 3 | Pages: e48-e48

10.1213/ane.0000000000003985 | PMID 30649070 Get It

Morphology of the Musculus Uvulae In Vivo Using MRI and 3D Modeling Among Adults With Normal Anatomy and Preliminary Comparisons to Cleft Palate Anatomy
Chen, Joshua Y., Kotlarek, Katelyn J. , Haenssler, Abigail E. , Sutton, Bradley P. , Kuehn, David P., Sitzman, Thomas J. , Perry, Jamie L. , Fang, Xiangming

Mayo Clinic

The Cleft Palate Craniofacial Journal | February 20, 2019 | Volume: 56 | Issue: 8 | Pages: 993-1000

10.1177/1055665619828226 | PMID 30786757 Get It

Purpose: To investigate the musculus uvulae morphology in vivo in adults with normal velopharyngeal anatomy and to examine sex and race effects on the muscle morphology. We also sought to provide a preliminary comparison of musculus uvulae morphology in adults with normal velopharyngeal anatomy to adults with repaired cleft palate. Methods: Three-dimensional magnetic resonance imaging data and Amira 5.5 Visualization Modeling software were used to evaluate the musculus uvulae in 70 participants without cleft palate and 6 participants with cleft palate. Muscle length, thickness, width, and volume were compared among participant groups. Results: Analysis of covariance analysis did not yield statistically significant differences in musculus uvulae length, thickness, width, or volume by race or sex among participants without cleft palate when the effect of body size was accounted for. Two-sample t test revealed that the musculus uvulae in participants with repaired cleft palate is significantly shorter ( P = .008, 13.65 mm vs 16.07 mm) and has less volume ( P = .002, 51.08 mm 3 vs 97.62 mm 3 ) than participants without cleft palate. Conclusion: In adults with normal velopharyngeal anatomy, the musculus uvulae is a cylindrical oblong-shaped muscle lying on the nasal surface of the soft palate, with its greatest bulk located just nasal to the levator veli palatini muscle sling. In participants with repaired cleft palate, the musculus uvulae is substantially reduced in volume. This diminished muscle bulk located just at the point where the palate contacts the posterior pharyngeal wall may contribute to velopharyngeal insufficiency in children with repaired cleft palate.
Predictors of Bloodstream Infection in Patients Presenting With Cardiovascular Implantable Electronic Device Pocket Infection
Garrigos, Zerelda Esquer , George, Merit P., Khalil, Sarwat , Vijayvargiya, Prakhar , Saleh, Omar Abu , Friedman, Paul A. , Steckelberg, James M., Wilson, Walter R., Sohail, M. Rizwan , Esquer Garrigos, Zerelda , Abu Saleh, Omar M, Sohail, M Rizwan , DeSimone, Daniel C. , Baddour, Larry M.

Mayo Clinic

Open Forum Infectious Diseases | February 20, 2019 | Volume: 6 | Issue: 4 | Pages: No page available

10.1093/ofid/ofz084 | PMID 30997366 Get It

Breast Cancer, Version 3.2018
Gradishar, William J. , Anderson, Benjamin O. , Abraham, Jame , Aft, Rebecca , Allison, Kimberly H. , Blair, Sarah L. , Burstein, Harold J. , Dang, Chau T. , Farrar, William B., Goldstein, Lori J. , Isakoff, Steven J. , Lyons, Janice A., Moran, Meena S. , O'Regan, Ruth M., Patel, Sameer A. , Pierce, Lori J. , Reed, Elizabeth , Sitapati, Amy M. , Smith, Mary Lou , Telli, Melinda L. , Shead, Dorothy A. , Goetz, Matthew P. , Elias, Anthony , Giordano, Sharon H. , Marcom, Paul Kelly , Mayer, Ingrid A. , Mortimer, Joanne , Rugo, Hope S. , Smith, Karen L. , Soliman, Hatem Hussein , Ward, John Headley , Young, Jessica S. , Kumar, Rashmi , Telli, Melinda L

Mayo Clinic

Journal of the National Comprehensive Cancer Network | February 20, 2019 | Volume: 17 | Issue: 2 | Pages: 118-126

10.6004/jnccn.2019.0009 | PMID 30787125 Get It

These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor–positive, HER2-negative early-stage invasive breast cancer. This report summarizes these updates and discusses the rationale behind them.
Relationship between asthma status and antibody response pattern to 23-valent pneumococcal vaccination
Sheen, Youn Ho, Kizilbash, Sarah J. , Park, Miguel , Abraham, Roshini S. , Ryu, Euijung , Divekar, Rohit , Juhn, Young J. , Sheen, Youn H, Kizilbash, Sarah, Ryoo, Eell, Juhn, Young, Ryoo, Eell , Wi, Chung‐Il , Kizilbash, Sarah

Mayo Clinic

Journal of Asthma | February 20, 2019 | Volume: 57 | Issue: 4 | Pages: 381-390

10.1080/02770903.2019.1575394 | PMID 30784333 Get It

Smaller Change in Psychological Readiness to Return to Sport Is Associated With Second Anterior Cruciate Ligament Injury Among Younger Patients
McPherson, April L. , Feller, Julian A. , Hewett, Timothy E. , Webster, Kate E.

Mayo Clinic

The American Journal of Sports Medicine | February 20, 2019 | Volume: 47 | Issue: 5 | Pages: 1209-1215

10.1177/0363546519825499 | PMID 30786247 Get It

Background: Lower psychological readiness to return to sport has been reported for younger patients (≤20 years) who go on to a second anterior cruciate ligament (ACL) injury. However, changes in psychological readiness and specific psychological responses associated with second injury have not been identified. Purpose/Hypothesis: To identify changes in psychological readiness over time associated with a second ACL injury. It was hypothesized that younger patients who suffered a second injury would have smaller changes in psychological readiness to return to sport when compared with those who did not have a second injury. Study Design: Case-control study; Level of evidence, 2. Methods: Patients ≤20 years old at the time of surgery who had a primary ACL reconstruction procedure between June 2014 and June 2016 were recruited for this study. The short version of the Anterior Cruciate Ligament Return to Sport After Injury (ACL-RSI) scale was completed by patients before their ACL reconstruction and repeated at 12 months after surgery to assess psychological readiness to return to sport. The primary outcome of interest was the relationship between the change in psychological readiness and second ACL injuries. Results: Among 115 young patients who returned to sport after ACL reconstruction, 21 (18%) experienced a second ACL injury. Injured patients did not show improvement in their ACL-RSI score between the preoperative assessment and 12-month time point (58.5 vs 60.8 points, P = .60) and had a significantly smaller change when compared with noninjured patients (9.2 vs 24.9 points, P = .01). When compared with the noninjured group, the injured group reported they were more nervous about playing sport, less confident in playing sport without concern for the knee, more frustrated with having to consider the knee with respect to sport, and more fearful of reinjuring the knee by playing sport ( P≤ .05). Conclusion: Injured patients exhibited less improvement in psychological readiness at a group level and reported different psychological characteristics with regard to return to sport at 12 months after ACL reconstruction as monitored by the ACL-RSI scale.